OBJECTIVE

2

To compare the contents of the instructions of domestic and imported Chinese patent medicines as well as those from Hong Kong， Macao and Taiwan， and to explore the feasibility of Chinese patent medicines to strengthen the use of medicine according to disease differentiation.

METHODS

2

The domestic Chinese patent medicines included in national medical insurance list as well as imported Chinese patent medicines and those from Hong Kong， Macao and Taiwan regions publicized on the official website of National Medical Products Administration were searched to statistically analyze the information of “functions” and “indications” in the instructions of Chinese patent medicines.

RESULTS

2

Finally， 1 311 instructions of domestic Chinese patent medicine and 43 of imported Chinese patent medicine and those from Hong Kong， Macao and Taiwan regions were screened out. In the “functions” item contained in the instructions of Chinese patent medicines， 94.04% domestic Chinese patent medicines， 87.50% imported ones and those from Hong Kong， Macao and Taiwan regions were expressed using the terms of traditional Chinese medicine； 4.89% and 12.50% were expressed using the terms of integrated Chinese and western medicine. The “functions” item were only expressed using the terms of western medicine in 1.07% of the instructions of domestic Chinese patent medicines. The “functions” item was mostly expressed using the terms of integrated Chinese and western medicine in the instructions of imported Chinese patent medicines and those from Hong Kong， Macao， and Taiwan regions， but there was no expressed using the terms of western medicine alone. Among the expressions of “functions” item containing the terms of western medicine， anti-inflammatory medicines accounted for the highest proportion， and domestic Chinese patent medicines， imported Chinese patent medicines and ones from Hong Kong， Macao and Taiwan regions accounted for 37.18% and 75.00%， respectively. In the instructions of domestic Chinese patent medicines， the “indications” item of which contained syndrome information accounted for 72.39%， and the instructions of imported Chinese patent medicines and those from Hong Kong， Macao and Taiwan regions which did not include syndromes information accounted for 74.42%； in the instructions of domestic Chinese patent medicines， imported ones and those from Hong Kong， Macao and Taiwan regions， the “indications” item of which contained disease information， accounted for 78.34% and 41.86%， respectively， and the “indications” item of which were mainly expressed using the terms of western medicine diseases， accounted for 64.85% and 73.68%， respectively.

CONCLUSIONS

2

Most of the domestic Chinese patent medicines included in the national medical insurance list have the basis for the use of disease differentiation； most of the imported Chinese patent medicines and those from Hong Kong， Macao and Taiwan regions have the basis for the use of disease differentiation.